- Home
- ATOM vs SLS Comparison
ATOM vs SLS Comparison
Compare ATOM & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- SLS
- Stock Information
- Founded
- ATOM 2001
- SLS 2012
- Country
- ATOM United States
- SLS United States
- Employees
- ATOM N/A
- SLS N/A
- Industry
- ATOM Semiconductors
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- SLS Health Care
- Exchange
- ATOM Nasdaq
- SLS Nasdaq
- Market Cap
- ATOM 155.4M
- SLS 185.3M
- IPO Year
- ATOM 2016
- SLS N/A
- Fundamental
- Price
- ATOM $3.27
- SLS $1.86
- Analyst Decision
- ATOM
- SLS Strong Buy
- Analyst Count
- ATOM 0
- SLS 1
- Target Price
- ATOM N/A
- SLS $7.00
- AVG Volume (30 Days)
- ATOM 285.9K
- SLS 1.9M
- Earning Date
- ATOM 10-28-2025
- SLS 08-12-2025
- Dividend Yield
- ATOM N/A
- SLS N/A
- EPS Growth
- ATOM N/A
- SLS N/A
- EPS
- ATOM N/A
- SLS N/A
- Revenue
- ATOM $49,000.00
- SLS N/A
- Revenue This Year
- ATOM $202.22
- SLS N/A
- Revenue Next Year
- ATOM $100.00
- SLS N/A
- P/E Ratio
- ATOM N/A
- SLS N/A
- Revenue Growth
- ATOM N/A
- SLS N/A
- 52 Week Low
- ATOM $2.31
- SLS $0.77
- 52 Week High
- ATOM $17.55
- SLS $2.27
- Technical
- Relative Strength Index (RSI)
- ATOM 39.42
- SLS 53.02
- Support Level
- ATOM $3.06
- SLS $1.75
- Resistance Level
- ATOM $3.44
- SLS $2.01
- Average True Range (ATR)
- ATOM 0.18
- SLS 0.12
- MACD
- ATOM 0.06
- SLS 0.01
- Stochastic Oscillator
- ATOM 36.82
- SLS 46.77
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.